12 Results for "

KG1

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "KG1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P9939
CAS No.: 1610833-03-8
Synonyms: KRN23; N5KG1_C10_LH; UX-023

Target:  

Inhibitory Antibodies

Research Areas:  

Metabolic Disease Cancer

Burosumab (KRN23) is a humanized FGF23-neutralizing antibody. By neutralizing FGF23, Burosumab blocks its inhibitory effect on renal phosphate reabsorption, thereby increasing serum phosphate levels and improving abnormal bone mineralization. Burosumab can be used in the research of diseases such as X-linked hypophosphatemia (XLH) and osteomalacia [1] .
loading...
    loading...
Cat. No.: HY-170952
CAS No.: 3053857-55-6
Target:  

Molecular Glues

Research Areas:  

Cancer

LYG-409 is an orally active degrader of GSPT1. LYG-409 shows excellent anti-acute myeloid leukemia and prostate cancer in vivo with TGI of 94.34% and 104.49%, respectively. LYG-409 inhibits KG-1 cells mediated by the degradation of GSPT1 with an IC50 of 9.50 nM, with a DC50 of 7.87 nM in vitro [1].
loading...
    loading...
Cat. No.: HY-142656
Target:  

Pim

Research Areas:  

Cancer

PIM-IN-1 is a pan-PIM kinase inhibitor (KG-1, EC50 = 61 nM; pS6, EC50 = 71 nM).
loading...
    loading...
Cat. No.: HY-155529
CAS No.: 1422456-47-0
Target:  

Pim

Research Areas:  

Cancer

FD1024 is PIM inhibitor (IC50s: 1.96, 38.9, 4.17 nM for PIM1, 2, 3). FD1024 can be used for research of acute myeloid leukemia. FD1024 has strong antiproliferative activity against the tested AML cell lines, with 0.16 μM, 0.12 μM, 1.05 μM, 1.39μM for EOL-1, MV-4-11, KG-1, MOLM-16 cells. FD1024 also has antitumor efficacy in mice [1].
loading...
    loading...
Cat. No.: HY-168082
Research Areas:  

Cancer

Dot1L-IN-8 (Compound 15) is a potent Dot1L inhibitor. Dot1L-IN-8 inhibits HL-60, K562, MV4-11, HH, and KG-1 cells vitality with IC50s of 0.45, 1.03, 0.68, 1.66, and 1.12 μM, respectively [1].
loading...
    loading...
Cat. No.: HY-149522
CAS No.: 3034883-70-7
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Cancer

BCL6-IN-10 (Compound WK499) is a BCL6 inhibitor. BCL6-IN-10 interrupts the binding of BCL6 to SMRT protein. BCL6-IN-10 induces cell apoptosis, cell cycle arrest and DNA damage. BCL6-IN-10 inhibits AML cell proliferation (IC50s: 0.91, 1.63, 1.026, 7.42, 0.87, 0.85μM for OCl-AML3, THP1, MOLM13, HL60, KG1, NB4 cell respectively) [1].
loading...
    loading...
Cat. No.: HY-W261325
CAS No.: 459137-97-4
Target:  

FGFR

Research Areas:  

Cancer

FGFR1 inhibitor-15 (Compound 23) is an FGFR1 inhibitor with an IC50 of 27 μM. FGFR1 inhibitor-15 can be used in the study of cancer [1].
loading...
    loading...
Cat. No.: HY-133030
CAS No.: 2396691-28-2
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

DNMT-IN-1 is a potent DNMT inhibitor with an EC50 value of 3.2 µM. DNMT-IN-1 shows antiproliferative active [1].
loading...
    loading...
Cat. No.: HY-P84580
Synonyms: ESET; KG1T; KMT1E; KIAA0067; H3-K9-HMTase4; SETDB1

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Monkey

loading...
    loading...
Cat. No.: HY-184811
CAS No.: 2698319-19-4
Target:  

Pim

Research Areas:  

Cancer

PIM-IN-6 is an inhibitor of PIM1 and PIM2, with an IC50 of 254 nM against PIM1 and an IC50 of 1.78 μM against PIM2. PIM-IN-6 can be used for the research of acute myeloid leukemia [1].
loading...
    loading...
Cat. No.: HY-P84580A
Synonyms: ESET; KG1T; KMT1E; KIAA0067; H3-K9-HMTase4; SETDB1

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Monkey

loading...
    loading...
Cat. No.: HY-183198
CAS No.: 2139294-71-4
Target:  

Pim

Research Areas:  

Cancer

PIM-IN-5 is a PIM kinase inhibitor. PIM-IN-5 can be used for the research of acute myeloid leukemia [1].
loading...
    loading...
  • 1